Please login to the form below

Not currently logged in

Novartis' German poster campaign to raise vaccination awareness

In-house designed work aims to educate public about meningococcal bacteria

Novartis office 

Novartis has launched a German poster campaign to raise public about meningococcal bacteria and vaccinations.

Backed by the Berlin Centre for Travel and Tropical Medicine, the campaign's posters will be displayed in 350 Sanifair toilets in Tank & Rast GmbH Travelers service stations across the country.

The campaign was conceived in-house by Christian Wieszner and Björn Kapplinghaus, of Novartis Vaccines' Eastern Europe and Central Europe marketing divisions, and its organisers expect the posters to be seen by some 62 million people by the end of March.

Meningococcal bacteria can be transmitted through droplet infection when coughing, sneezing, or kissing. It is a particular risk when the immune system is weakened by other infections, allowing the bacteria to multiply, and potentially leading to meningitis and blood poisoning.

The company's meningococcal B vaccine, Bexsaro, won European approval last year and was launched in Germany in December.

The campaign is not the first time Novartis Vaccines has used motorway service areas as the backdrop and follows its 2009 motorway campaign educating the public about seasonal influenza.

A survey among travellers at that time showed that nearly half of the respondents could recall details of the poster. The survey found participants predominantly in favour of posters educating them about health risks.

Article by
Tara Craig

26th March 2014

From: Marketing



Featured jobs

Subscribe to our email news alerts


Add my company
PRMA Consulting Ltd

PRMA Consulting is an independent consultancy solving some of the most challenging pricing, reimbursement and market access issues facing international...

Latest intelligence

Report: Achieving launch excellence in the challenging healthcare markets of today
Our in-depth report is based on original data and expert interviews, which coupled with our own experience, ensures we give you the best recommendations for achieving launch success in challenging...
What is blockchain and why should i care - Richard Springham
Four Health - Emerging Technologies The power of blockchain lies in the fact it can prove that a unique event occurred at a certain time with out the need to...
NHS medicines optimisation milestone
Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare Consulting Team, explore the implications of Adalimumab’s recent European patent expiry...